Video Library

Learn how 4 AONN+ conference attendees grew their relationship from first exchanging casual messages in the chat box of a virtual conference, to regular meetings, and now, to a virtual learning network. According to Dani Alston, MMS, OPN-CG, Patient Navigator and one of the founding members, the “started the group [they] wish [they] had when [they] first started [their] career in navigation.”

Join us in sunny Orlando for the AONN+ 2023 Midyear Conference.

At AONN+, we believe that the more passionate you are about your work, the more impact you will create. In this video series titled “What’s Your Why?” AONN+ leaders and members share the intentions and motivations behind their careers in oncology navigation. Director of AONN+ Program Development Jordan Henderson explains, “I always say ‘Oncology care should not be discussed without navigation,’ that’s how much I believe in it.”

AONN+’s BOLD Mentorship Academy matches mentees and mentors to support and educate one another, pairing applicants based on shared goals, strengths, and expertise. Navigators of all disciplines are encouraged to “Be BOLD,” and seek out opportunities to grow personally and professionally by using the tools provided through this platform! Hear from Alison McDaniel, RN, BSN, OCN, ONN-CG, Manager of Oncology Navigation at Oschner Health, and Kayla Byrd, RN, OCN, Breast Health Navigator, Baptist Health System, on why you shouldn’t hesitate to participate in this program.

Watch as our CLL clinical advisor dives deeper into defining CLL, the clinical staging systems developed for this disease, and the role navigators play in the patient’s treatment journey.

Listen in as our CLL clinical advisor examines the “Watch and Wait” period in CLL and impact navigation can have during this period.

A look at understanding the complexities of mutations and cytogenetics in CLL, the role genetics plays in prognosis, and how navigators can educate their patients and caregivers.

An inspection of prognostic and predictive tools in CLL, risk categories, and impact on the patient’s treatment plan.

Our CLL clinical advisor examines indications for treatment in CLL for both symptomatic patients and asymptomatic patients as well as the navigator’s touchpoints during this phase.